亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

武漢嘉凱隆精細(xì)化工科技發(fā)展有限公司  

制藥廠醫(yī)藥廠精細(xì)化工廠

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:黃思
  • 電話:027-88422011
  • 郵件:huangsi001hot@163.com
  • 傳真:027-88774279
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 硫酸氫氯吡格雷
硫酸氫氯吡格雷
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
過期 長(zhǎng)期有效
更新 2011-04-12 14:46
 
詳細(xì)信息

硫酸氫氯吡格雷
英文名:Clopidogrel Bisulfate
CAS NO.:120202-66-6
分子式:C16H16ClNO2S.H2SO4
分子量: 419.9
適應(yīng)癥:中風(fēng),心肌梗死
質(zhì)量標(biāo)準(zhǔn):USP29
有關(guān)物質(zhì):A<0.1%,B<0.2%,C<0.5%,其他雜質(zhì)<0.1%,總雜質(zhì)<1.0%
含量:>99.0%
聯(lián)系人:黃思
電 話:027-88422011-15871493887
©2025 武漢嘉凱隆精細(xì)化工科技發(fā)展有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:8843  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |